Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells.
Type 1 diabetes mellitus (T1DM) is a result of autoimmune destruction of insulin-producing beta cells of pancreas. Insulin is a widely used therapeutic modality. Nearing a complete century since the discovery of insulin, it is time to expect change in man..... Read More